AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionSageView Advisory Group, LLC
Latest Disclosed Ownership33,628 shares
Latest Disclosed Value $ 7,683,605
SageView Advisory Group, LLC reports 7.38% decrease in ownership of 4AB / AbbVie Inc.

On February 17, 2026 - SageView Advisory Group, LLC filed a 13F-HR form disclosing ownership of 33,628 shares of AbbVie Inc. (BG:4AB) valued at $7,683,605 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 36,307 shares of AbbVie Inc.. This represents a change in shares of -7.38% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F ABBVIE COM 00287Y109 33,628 -2,679 -7.38 7,684 -8.60 0.2598
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 36,307 13,883 61.91 8,406 98.86 0.2901
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 22,424 4,020 21.84 4,227 9.65 0.1599
2025-05-19 2025-03-31 13F ABBVIE COM 00287Y109 18,404 474 2.64 3,856 21.00 0.1644
2025-02-13 2024-12-31 13F ABBVIE COM 00287Y109 17,930 5,327 42.27 3,186 28.05 0.1371
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 12,603 -5,862 -31.75 2,489 -21.44 0.1263
2024-08-15 2024-06-30 13F/A-1 ABBVIE COM 00287Y109 18,465 3,935 27.08 3,167 19.69 0.1471
2024-08-12 2024-06-30 13F ABBVIE COM 00287Y109 14,530 0 2,646 0.1194
2024-05-09 2024-03-31 13F ABBVIE COM 00287Y109 14,530 -7,768 -34.84 2,646 -28.04 0.1336
2024-03-06 2023-12-31 13F/A-2 ABBVIE COM 00287Y109 22,298 9,460 73.69 3,677 92.21 0.1583
2024-02-16 2023-12-31 13F/A-1 ABBVIE COM 00287Y109 22,298 9,460 3,677 0.1571
2024-02-09 2023-12-31 13F ABBVIE COM 00287Y109 22,298 9,460 3,677 0.1571
2023-11-03 2023-09-30 13F ABBVIE COM 00287Y109 12,838 -188 -1.44 1,914 9.06 0.1096
2023-08-11 2023-06-30 13F ABBVIE COM 00287Y109 13,026 -242 -1.82 1,755 -17.03 0.0977
2023-05-02 2023-03-31 13F ABBVIE COM 00287Y109 13,268 3,142 31.03 2,115 29.22 0.1348
2023-02-15 2022-12-31 13F ABBVIE COM 00287Y109 10,126 10,126 1,637 0.1329
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.